Cost-of-illness analysis of ulcerative colitis patients treated with biological therapy: a prospective observational study in Iran
Biological therapies accounted for the largest share of direct medical expenses, while productivity losses, mainly resulting from temporary absenteeism, were identified as a major factor contributing to the economic burden of UC in Iran.
Authors
- Ali Mouseli (ORCID: https://orcid.org/0000-0003-0853-5184)
- Maryam Shirvani Shiri (ORCID: https://orcid.org/0000-0002-8612-5204)
- Amin Ghanbarnejad (ORCID: https://orcid.org/0000-0002-6623-4163)
- Reihaneh Taheri Kondar (ORCID: https://orcid.org/0000-0003-2711-4377)
- Hassan Karami (ORCID: https://orcid.org/0000-0002-0239-2779)
- Farbod Ebadi Fard Azar
- Mitra Nowrouzpour
Institutions
- Iran University of Medical Sciences (IR)
- Hormozgan University of Medical Sciences (IR)
Publication Details
- Journal
- BMC Health Services Research
- Published
- 2025-03-05
- DOI
- https://doi.org/10.1186/s12913-025-12474-6
- Citations
- 1
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 1.82